Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects

Completed · Not applicable

Conditions studied: Psychiatric Disorder

In brief

The Researchers are trying to learn more about how individuals break down and process medications based on their genes. The Researchers want to find out whether subjects will have fewer side effects if they take different medications based on their pharmacogenomics profile.

Key facts

Study ID

NCT03748355

Run by

Mayo Clinic

People needed

80

Starts

2018-10-14

Expected to finish

2020-01-02

Last updated by the study team

2020-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ages 18 and older
• Hospitalized on Generose 2E (Acute Care Psychiatry), 3E (Medical and Geriatric Psychiatry), or 3W (Mood Disorders Unit).
• A voluntary patient
• Having 5 or more medications (scheduled or as needed) on their medication list.
• Ability to give informed consent

You may not qualify if…

• Patient with cognitive impairments such as moderate to severe dementia.
• Patients who do not communicate in English or cannot comprehend the rating scales used.
• Patients who have had pharmacogenetics testing performed within the previous 5 years.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.